Perspective
An Ounce of Prevention is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001
Protocols for mass antibiotic prophylaxis against anthrax were under development in New York City beginning in early 1999. This groundwork allowed the city’s Department of Health to rapidly respond in 2001 to six situations in which cases were identified or anthrax spores were found. The key aspects of planning and lessons learned from each of these mass prophylaxis operations are reviewed. Antibiotic distribution was facilitated by limiting medical histories to issues relevant to prescribing prophylactic antibiotic therapy, formatting medical records to facilitate rapid decision making, and separating each component activity into discrete work stations. Successful implementation of mass prophylaxis operations was characterized by clarity of mission and eligibility criteria, well-defined lines of authority and responsibilities, effective communication, collaboration among city agencies (including law enforcement), and coordination of staffing and supplies. This model can be adapted for future planning needs including possible attacks with other bioterrorism agents, such as smallpox.
EID | Blank S, Moskin LC, Zucker JR. An Ounce of Prevention is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001. Emerg Infect Dis. 2003;9(6):615-622. https://doi.org/10.3201/eid0906.030118 |
---|---|
AMA | Blank S, Moskin LC, Zucker JR. An Ounce of Prevention is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001. Emerging Infectious Diseases. 2003;9(6):615-622. doi:10.3201/eid0906.030118. |
APA | Blank, S., Moskin, L. C., & Zucker, J. R. (2003). An Ounce of Prevention is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001. Emerging Infectious Diseases, 9(6), 615-622. https://doi.org/10.3201/eid0906.030118. |
Synopses
Inactivation of Bacillus anthracis Spores
After the intentional release of Bacillus anthracis through the U.S. Postal Service in the fall of 2001, many environments were contaminated with B. anthracis spores, and frequent inquiries were made regarding the science of destroying these spores. We conducted a survey of the literature that had potential application to the inactivation of B. anthracis spores. This article provides a tabular summary of the results.
EID | Whitney EA, Beatty ME, Taylor TH, Weyant R, Sobel J, Arduino MJ, et al. Inactivation of Bacillus anthracis Spores. Emerg Infect Dis. 2003;9(6):623-627. https://doi.org/10.3201/eid0906.020377 |
---|---|
AMA | Whitney EA, Beatty ME, Taylor TH, et al. Inactivation of Bacillus anthracis Spores. Emerging Infectious Diseases. 2003;9(6):623-627. doi:10.3201/eid0906.020377. |
APA | Whitney, E. A., Beatty, M. E., Taylor, T. H., Weyant, R., Sobel, J., Arduino, M. J....Ashford, D. A. (2003). Inactivation of Bacillus anthracis Spores. Emerging Infectious Diseases, 9(6), 623-627. https://doi.org/10.3201/eid0906.020377. |
Research
Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong
Human metapneumovirus (HMPV) is a newly discovered pathogen thought to be associated with respiratory disease. We report the results of a study of 587 children hospitalized with respiratory infection over a 13-month period. HMPV was detected in the nasopharyngeal aspirates from 32 (5.5%) children by reverse transcription-polymerase chain reaction. HMPV infection was associated with clinical diagnoses of pneumonia (36%), asthma exacerbation (23%), or acute bronchiolitis (10%). When compared to those with respiratory syncytial virus infection, children with HMPV infection were older, and wheezing was more likely to represent asthma exacerbation rather than acute bronchiolitis. HMPV viral activity peaked during the spring-summer period in Hong Kong. Phylogenetically, all HMPV virus strains from Hong Kong belonged to one of the two genetic lineages previously described. HMPV contributed to 441.6 hospital admissions per 100,000 population <6 years of age.
EID | Peiris JM, Tang W, Chan K, Khong P, Guan Y, Lau Y, et al. Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong. Emerg Infect Dis. 2003;9(6):628-633. https://doi.org/10.3201/eid0906.030009 |
---|---|
AMA | Peiris JM, Tang W, Chan K, et al. Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong. Emerging Infectious Diseases. 2003;9(6):628-633. doi:10.3201/eid0906.030009. |
APA | Peiris, J. M., Tang, W., Chan, K., Khong, P., Guan, Y., Lau, Y....Chiu, S. S. (2003). Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong. Emerging Infectious Diseases, 9(6), 628-633. https://doi.org/10.3201/eid0906.030009. |
Human Metapneumovirus Infections in Hospitalized Children
We evaluated the percentage of hospitalizations for acute respiratory tract infections in children <3 years of age attributable to human metapneumovirus (HMPV) and other respiratory viruses in a prospective study during winter and spring 2002. We used real-time polymerase chain assays and other conventional diagnostic methods to detect HMPV, human respiratory syncytial virus (HRSV), and influenza viruses in nasopharyngeal aspirates of children. HMPV was detected in 12 (6%) of the 208 children hospitalized for acute respiratory tract infections, HRSV in 118 (57%), and influenza A in 49 (24%). Bronchiolitis was diagnosed in 8 (68%) and pneumonitis in 2 (17%) of HMPV-infected children; of those with HRSV infection, pneumonitis was diagnosed in 99 (84%) and bronchiolitis in 30 (25%). None of the HMPV-infected children was admitted to an intensive-care unit, whereas 15% of those with HRSV or influenza A infections were admitted. HMPV is an important cause of illness in young children with a similar, although less severe, clinical presentation to that of HRSV.
EID | Boivin G, De Serres G, Côté S, Gilca R, Abed Y, Rochette L, et al. Human Metapneumovirus Infections in Hospitalized Children. Emerg Infect Dis. 2003;9(6):634-640. https://doi.org/10.3201/eid0906.030017 |
---|---|
AMA | Boivin G, De Serres G, Côté S, et al. Human Metapneumovirus Infections in Hospitalized Children. Emerging Infectious Diseases. 2003;9(6):634-640. doi:10.3201/eid0906.030017. |
APA | Boivin, G., De Serres, G., Côté, S., Gilca, R., Abed, Y., Rochette, L....Déry, P. (2003). Human Metapneumovirus Infections in Hospitalized Children. Emerging Infectious Diseases, 9(6), 634-640. https://doi.org/10.3201/eid0906.030017. |
Dead Bird Clusters as an Early Warning System for West Nile Virus Activity
An early warning system for West Nile virus (WNV) outbreaks could provide a basis for targeted public education and surveillance activities as well as more timely larval and adult mosquito control. We adapted the spatial scan statistic for prospective detection of infectious disease outbreaks, applied the results to data on dead birds reported from New York City in 2000, and reviewed its utility in providing an early warning of WNV activity in 2001. Prospective geographic cluster analysis of dead bird reports may provide early warning of increasing viral activity in birds and mosquitoes, allowing jurisdictions to triage limited mosquito-collection and laboratory resources and more effectively prevent human disease caused by the virus. This adaptation of the scan statistic could also be useful in other infectious disease surveillance systems, including that for bioterrorism.
EID | Mostashari F, Kulldorff M, Hartman JJ, Miller JR, Kulasekera V. Dead Bird Clusters as an Early Warning System for West Nile Virus Activity. Emerg Infect Dis. 2003;9(6):641-646. https://doi.org/10.3201/eid0906.020794 |
---|---|
AMA | Mostashari F, Kulldorff M, Hartman JJ, et al. Dead Bird Clusters as an Early Warning System for West Nile Virus Activity. Emerging Infectious Diseases. 2003;9(6):641-646. doi:10.3201/eid0906.020794. |
APA | Mostashari, F., Kulldorff, M., Hartman, J. J., Miller, J. R., & Kulasekera, V. (2003). Dead Bird Clusters as an Early Warning System for West Nile Virus Activity. Emerging Infectious Diseases, 9(6), 641-646. https://doi.org/10.3201/eid0906.020794. |
Gnathostomiasis: An Emerging Imported Disease
As the scope of international travel expands, an increasing number of travelers are coming into contact with helminthic parasites rarely seen outside the tropics. As a result, the occurrence of Gnathostoma spinigerum infection leading to the clinical syndrome gnathostomiasis is increasing. In areas where Gnathostoma is not endemic, few clinicians are familiar with this disease. To highlight this underdiagnosed parasitic infection, we describe a case series of patients with gnathostomiasis who were treated during a 12-month period at the Hospital for Tropical Diseases, London.
EID | Moore DA, McCrodden J, Dekumyoy P, Chiodini P. Gnathostomiasis: An Emerging Imported Disease. Emerg Infect Dis. 2003;9(6):647-650. https://doi.org/10.3201/eid0906.020625 |
---|---|
AMA | Moore DA, McCrodden J, Dekumyoy P, et al. Gnathostomiasis: An Emerging Imported Disease. Emerging Infectious Diseases. 2003;9(6):647-650. doi:10.3201/eid0906.020625. |
APA | Moore, D. A., McCrodden, J., Dekumyoy, P., & Chiodini, P. (2003). Gnathostomiasis: An Emerging Imported Disease. Emerging Infectious Diseases, 9(6), 647-650. https://doi.org/10.3201/eid0906.020625. |
Histopathologic Features of Mycobacterium ulcerans Infection
Because of the emergence of Buruli ulcer disease, the World Health Organization launched a Global Buruli Ulcer Initiative in 1998. This indolent skin infection is caused by Mycobacterium ulcerans. During a study of risk factors for the disease in Ghana, adequate excisional skin-biopsy specimens were obtained from 124 clinically suspicious lesions. Buruli ulcer disease was diagnosed in 78 lesions since acid-fast bacilli (AFB) were found by histopathologic examination. Lesions with other diagnoses included filariasis (3 cases), zygomycosis (2 cases), ulcerative squamous cell carcinomas (2 cases), keratin cyst (1 case), and lymph node (1 case). Thirty-seven specimens that did not show AFB were considered suspected Buruli ulcer disease cases. Necrosis of subcutaneous tissues and dermal collagen were found more frequently in AFB-positive specimens compared with specimens from suspected case-patients (p<0.001). Defining histologic criteria for a diagnosis of Buruli ulcer disease is of clinical and public health importance since it would allow earlier treatment, leading to less deforming sequelae.
EID | Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, Asamoa K, et al. Histopathologic Features of Mycobacterium ulcerans Infection. Emerg Infect Dis. 2003;9(6):651-656. https://doi.org/10.3201/eid0906.020485 |
---|---|
AMA | Guarner J, Bartlett J, Whitney EA, et al. Histopathologic Features of Mycobacterium ulcerans Infection. Emerging Infectious Diseases. 2003;9(6):651-656. doi:10.3201/eid0906.020485. |
APA | Guarner, J., Bartlett, J., Whitney, E. A., Raghunathan, P. L., Stienstra, Y., Asamoa, K....Ashford, D. A. (2003). Histopathologic Features of Mycobacterium ulcerans Infection. Emerging Infectious Diseases, 9(6), 651-656. https://doi.org/10.3201/eid0906.020485. |
Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) with heterogeneously reduced susceptibility to vancomycin. Bloodstream MRSA isolates were screened for reduced susceptibility by using brain-heart infusion agar, including 4 mg/L vancomycin with and without 4% NaCl. Patients whose isolates exhibited growth (case-patients) were compared with those whose isolates did not (controls) for demographics, coexisting chronic conditions, hospital events, antibiotic exposures, and outcomes. Sixty-one (41%) of 149 isolates exhibited growth. Subclones from 46 (75%) of these had a higher MIC of vancomycin than did their parent isolates. No isolates met criteria for vancomycin heteroresistance. No differences in potential predictors or in outcomes were found between case-patients and controls. These data show that patients with vancomycin-susceptible MRSA bacteremia have similar baseline clinical features and outcomes whether or not their bacterial isolates exhibit growth on screening media containing vancomycin.
EID | Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, et al. Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia. Emerg Infect Dis. 2003;9(6):657-664. https://doi.org/10.3201/eid0906.030001 |
---|---|
AMA | Schwaber MJ, Wright SB, Carmeli Y, et al. Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia. Emerging Infectious Diseases. 2003;9(6):657-664. doi:10.3201/eid0906.030001. |
APA | Schwaber, M. J., Wright, S. B., Carmeli, Y., Venkataraman, L., DeGirolami, P. C., Gramatikova, A....Gold, H. S. (2003). Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia. Emerging Infectious Diseases, 9(6), 657-664. https://doi.org/10.3201/eid0906.030001. |
Serogroup W-135 Meningococcal Disease during the Hajj, 2000
An outbreak of serogroup W-135 meningococcal disease occurred during the 2000 Hajj in Saudi Arabia. Disease was reported worldwide in Hajj pilgrims and their close contacts; however, most cases were identified in Saudi Arabia. Trends in Saudi meningococcal disease were evaluated and the epidemiology of Saudi cases from this outbreak described. Saudi national meningococcal disease incidence data for 1990 to 2000 were reviewed; cases from January 24 to June 5, 2000 were retrospectively reviewed. The 2000 Hajj outbreak consisted of distinct serogroup A and serogroup W-135 outbreaks. Of 253 identified cases in Saudi Arabia, 161 (64%) had serogroup identification; serogroups W-135 and A caused 93 (37%) and 60 (24%) cases with attack rates of 9 and 6 cases per 100,000 population, respectively. The 2000 Hajj outbreak was the first large serogroup W-135 meningococcal disease outbreak identified worldwide. Enhanced surveillance for serogroup W-135, especially in Africa, is essential to control this emerging epidemic disease.
EID | Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, et al. Serogroup W-135 Meningococcal Disease during the Hajj, 2000. Emerg Infect Dis. 2003;9(6):665-671. https://doi.org/10.3201/eid0906.020565 |
---|---|
AMA | Lingappa JR, Al-Rabeah AM, Hajjeh R, et al. Serogroup W-135 Meningococcal Disease during the Hajj, 2000. Emerging Infectious Diseases. 2003;9(6):665-671. doi:10.3201/eid0906.020565. |
APA | Lingappa, J. R., Al-Rabeah, A. M., Hajjeh, R., Mustafa, T., Fatani, A., Al-Bassam, T....Rosenstein, N. E. (2003). Serogroup W-135 Meningococcal Disease during the Hajj, 2000. Emerging Infectious Diseases, 9(6), 665-671. https://doi.org/10.3201/eid0906.020565. |
Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001
On November 20, 2001, inhalational anthrax was confirmed in an elderly woman from rural Connecticut. To determine her exposure source, we conducted an extensive epidemiologic, environmental, and laboratory investigation. Molecular subtyping showed that her isolate was indistinguishable from isolates associated with intentionally contaminated letters. No samples from her home or community yielded Bacillus anthracis, and she received no first-class letters from facilities known to have processed intentionally contaminated letters. Environmental sampling in the regional Connecticut postal facility yielded B. anthracis spores from 4 (31%) of 13 sorting machines. One extensively contaminated machine primarily processes bulk mail. A second machine that does final sorting of bulk mail for her zip code yielded B. anthracis on the column of bins for her carrier route. The evidence suggests she was exposed through a cross-contaminated bulk mail letter. Such cross-contamination of letters and postal facilities has implications for managing the response to future B. anthracis–contaminated mailings.
EID | Griffith KS, Mead PS, Armstrong GL, Painter JA, Kelley KA, Hoffmaster AR, et al. Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001. Emerg Infect Dis. 2003;9(6):681-688. https://doi.org/10.3201/eid0906.020728 |
---|---|
AMA | Griffith KS, Mead PS, Armstrong GL, et al. Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001. Emerging Infectious Diseases. 2003;9(6):681-688. doi:10.3201/eid0906.020728. |
APA | Griffith, K. S., Mead, P. S., Armstrong, G. L., Painter, J. A., Kelley, K. A., Hoffmaster, A. R....Hadler, J. L. (2003). Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001. Emerging Infectious Diseases, 9(6), 681-688. https://doi.org/10.3201/eid0906.020728. |
Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001
On October 31, 2001, in New York City, a 61-year-old female hospital employee who had acquired inhalational anthrax died after a 6-day illness. To determine sources of exposure and identify additional persons at risk, the New York City Department of Health, Centers for Disease Control and Prevention, and law enforcement authorities conducted an extensive investigation, which included interviewing contacts, examining personal effects, summarizing patient’s use of mass transit, conducting active case finding and surveillance near her residence and at her workplace, and collecting samples from co-workers and the environment. We cultured all specimens for Bacillus anthracis. We found no additional cases of cutaneous or inhalational anthrax. The route of exposure remains unknown. All environmental samples were negative for B. anthracis. This first case of inhalational anthrax during the 2001 outbreak with no apparent direct link to contaminated mail emphasizes the need for close coordination between public health and law enforcement agencies during bioterrorism-related investigations.
EID | Holtz TH, Ackelsberg J, Kool JL, Rosselli R, Marfin A, Matte T, et al. Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001. Emerg Infect Dis. 2003;9(6):689-696. https://doi.org/10.3201/eid0906.020668 |
---|---|
AMA | Holtz TH, Ackelsberg J, Kool JL, et al. Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001. Emerging Infectious Diseases. 2003;9(6):689-696. doi:10.3201/eid0906.020668. |
APA | Holtz, T. H., Ackelsberg, J., Kool, J. L., Rosselli, R., Marfin, A., Matte, T....Layton, M. (2003). Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001. Emerging Infectious Diseases, 9(6), 689-696. https://doi.org/10.3201/eid0906.020668. |
Relapsing Fever–Like Spirochetes Infecting European Vector Tick of Lyme Disease Agent
To determine whether relapsing fever–like spirochetes associated with hard ticks may infect Ixodes ricinus ticks in central Europe, we screened questing ticks for 16S rDNA similar to that of Asian and American relapsing fever–like spirochetes. We compared the prevalence of these spirochetes to that of Lyme disease spirochetes transmitted by the same vector. Relapsing fever-like spirochetes infect 3.5% of questing vector ticks in our three central European sites near the Rhein Valley. These spirochetes differ genetically from their American and Asian analogs while being relatively homogeneous in the region we sampled. The Lyme disease genospecies most commonly detected in central Europe are distributed broadly, whereas those that are less frequently found appear to be place-specific. The absence of co-infected ticks suggests that relapsing fever–like and Lyme disease spirochetes may not share hosts. Exposure risk for relapsing fever–like spirochetes is similar to that of certain Lyme disease genospecies. Although many persons may be bitten by ticks infected by relapsing fever–like spirochetes, health implications remain unknown.
EID | Richter D, Schlee DB, Matuschka F. Relapsing Fever–Like Spirochetes Infecting European Vector Tick of Lyme Disease Agent. Emerg Infect Dis. 2003;9(6):697-701. https://doi.org/10.3201/eid0906.020459 |
---|---|
AMA | Richter D, Schlee DB, Matuschka F. Relapsing Fever–Like Spirochetes Infecting European Vector Tick of Lyme Disease Agent. Emerging Infectious Diseases. 2003;9(6):697-701. doi:10.3201/eid0906.020459. |
APA | Richter, D., Schlee, D. B., & Matuschka, F. (2003). Relapsing Fever–Like Spirochetes Infecting European Vector Tick of Lyme Disease Agent. Emerging Infectious Diseases, 9(6), 697-701. https://doi.org/10.3201/eid0906.020459. |
Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000
Adventure travel is becoming more popular, increasing the likelihood of contact with unusual pathogens. We investigated an outbreak of leptospirosis in “Eco-Challenge” multisport race athletes to determine illness etiology and implement public health measures. Of 304 athletes, we contacted 189 (62%) from the United States and 26 other countries. Eighty (42%) athletes met our case definition. Twenty-nine (36%) case-patients were hospitalized; none died. Logistic regression showed swimming in the Segama River (relative risk [RR]=2.0; 95% confidence interval [CI]=1.3 to 3.1) to be an independent risk factor. Twenty-six (68%) of 38 case-patients tested positive for leptospiral antibodies. Taking doxycycline before or during the race was protective (RR=0.4, 95% CI=0.2 to 1.2) for the 20 athletes who reported using it. Increased adventure travel may lead to more frequent exposure to leptospires, and preexposure chemoprophylaxis for leptospirosis (200 mg oral doxycycline/week) may decrease illness risk. Efforts are needed to inform adventure travel participants of unique infections such as leptospirosis.
EID | Sejvar J, Bancroft E, Winthrop KL, Bettinger J, Bajani M, Bragg S, et al. Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000. Emerg Infect Dis. 2003;9(6):702-707. https://doi.org/10.3201/eid0906.020751 |
---|---|
AMA | Sejvar J, Bancroft E, Winthrop KL, et al. Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000. Emerging Infectious Diseases. 2003;9(6):702-707. doi:10.3201/eid0906.020751. |
APA | Sejvar, J., Bancroft, E., Winthrop, K. L., Bettinger, J., Bajani, M., Bragg, S....Rosenstein, N. (2003). Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000. Emerging Infectious Diseases, 9(6), 702-707. https://doi.org/10.3201/eid0906.020751. |
Community Reaction to Bioterrorism: Prospective Study of Simulated Outbreak
To assess community needs for public information during a bioterrorism-related crisis, we simulated an intentional Rift Valley fever outbreak in a community in the southern part of the United States. We videotaped a series of simulated print and television “news reports” over a fictional 9-day crisis period and invited various groups (e.g., first-responders and their spouses or partners, journalists) within the selected community to view the videotape and respond to questions about their reactions. All responses were given anonymously. First-responders and their spouses or partners varied in their reactions about how the crisis affected family harmony and job performance. Local journalists exhibited considerable personal fear and confusion. All groups demanded, and put more trust in, information from local sources. These findings may have implications for risk communication during bioterrorism-related outbreaks.
EID | DiGiovanni C, Reynolds B, Harwell R, Stonecipher EB, Burkle FM. Community Reaction to Bioterrorism: Prospective Study of Simulated Outbreak. Emerg Infect Dis. 2003;9(6):708-712. https://doi.org/10.3201/eid0906.020769 |
---|---|
AMA | DiGiovanni C, Reynolds B, Harwell R, et al. Community Reaction to Bioterrorism: Prospective Study of Simulated Outbreak. Emerging Infectious Diseases. 2003;9(6):708-712. doi:10.3201/eid0906.020769. |
APA | DiGiovanni, C., Reynolds, B., Harwell, R., Stonecipher, E. B., & Burkle, F. M. (2003). Community Reaction to Bioterrorism: Prospective Study of Simulated Outbreak. Emerging Infectious Diseases, 9(6), 708-712. https://doi.org/10.3201/eid0906.020769. |
Molecular Subtyping To Detect Human Listeriosis Clusters
We analyzed the diversity (Simpson’s Index, D) and distribution of Listeria monocytogenes in human listeriosis cases in New York State (excluding New York City) from November 1996 to June 2000 by using automated ribotyping and pulsed-field gel electrophoresis (PFGE). We applied a scan statistic (p<0.05) to detect listeriosis clusters caused by a specific Listeria monocytogenes subtype. Among 131 human isolates, 34 (D=0.923) ribotypes and 74 (D=0.975) PFGE types were found. Nine (31% of cases) clusters were identified by ribotype or PFGE; five (18% of cases) clusters were identified by using both methods. Two of the nine clusters (13% of cases) corresponded with investigated multistate listeriosis outbreaks. While most human listeriosis cases are considered sporadic, highly discriminatory molecular subtyping approaches thus indicated that 13% to 31% of cases reported in New York State may represent single-source clusters. Listeriosis control and reduction efforts should include broad-based subtyping of human isolates and consider that a large number of cases may represent outbreaks.
EID | Sauders BD, Fortes ED, Morse DL, Dumas N, Kiehlbauch JA, Schukken Y, et al. Molecular Subtyping To Detect Human Listeriosis Clusters. Emerg Infect Dis. 2003;9(6):672-680. https://doi.org/10.3201/eid0906.020702 |
---|---|
AMA | Sauders BD, Fortes ED, Morse DL, et al. Molecular Subtyping To Detect Human Listeriosis Clusters. Emerging Infectious Diseases. 2003;9(6):672-680. doi:10.3201/eid0906.020702. |
APA | Sauders, B. D., Fortes, E. D., Morse, D. L., Dumas, N., Kiehlbauch, J. A., Schukken, Y....Wiedmann, M. (2003). Molecular Subtyping To Detect Human Listeriosis Clusters. Emerging Infectious Diseases, 9(6), 672-680. https://doi.org/10.3201/eid0906.020702. |
Dispatches
Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts
Severe acute respiratory syndrome (SARS) is an emerging viral infectious disease. One of the largest outbreaks of SARS to date began in Singapore in March 2003. We describe the clinical, laboratory, and radiologic features of the index patient and the patient’s initial contacts affected with probable SARS.
EID | Hsu L, Lee C, Green JA, Ang B, Paton NI, Lee L, et al. Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts. Emerg Infect Dis. 2003;9(6):713-717. https://doi.org/10.3201/eid0906.030264 |
---|---|
AMA | Hsu L, Lee C, Green JA, et al. Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts. Emerging Infectious Diseases. 2003;9(6):713-717. doi:10.3201/eid0906.030264. |
APA | Hsu, L., Lee, C., Green, J. A., Ang, B., Paton, N. I., Lee, L....Leo, Y. (2003). Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts. Emerging Infectious Diseases, 9(6), 713-717. https://doi.org/10.3201/eid0906.030264. |
Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan
As of April 14, 2003, Taiwan had had 23 probable cases of severe acute respiratory syndrome (SARS), all imported. Taiwan isolated these first 23 patients with probable SARS in negative-pressure rooms; extensive personal protective equipment was used for healthcare workers and visitors. For the first 6 weeks of the SARS outbreak, recognized spread was limited to one healthcare worker and three household contacts.
EID | Twu S, Chen T, Chen C, Olsen SJ, Lee L, Fisk T, et al. Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan. Emerg Infect Dis. 2003;9(6):718-720. https://doi.org/10.3201/eid0906.030283 |
---|---|
AMA | Twu S, Chen T, Chen C, et al. Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan. Emerging Infectious Diseases. 2003;9(6):718-720. doi:10.3201/eid0906.030283. |
APA | Twu, S., Chen, T., Chen, C., Olsen, S. J., Lee, L., Fisk, T....Dowell, S. F. (2003). Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan. Emerging Infectious Diseases, 9(6), 718-720. https://doi.org/10.3201/eid0906.030283. |
Human Rabies: A Reemerging Disease in Costa Rica?
Two human rabies cases caused by a bat-associated virus variant were identified in September 2001 in Costa Rica, after a 31-year absence of the disease in persons. Both patients lived in a rural area where cattle had a high risk for bat bites, but neither person had a definitive history of being bitten by a rabid animal. Characterization of the rabies viruses from the patients showed that the reservoir was the hematophagous Vampire Bat, Desmodus rotundus, and that a sick cat was the vector.
EID | Badilla X, Pérez-Herra V, Quirós L, Morice A, Jiménez E, Sáenz E, et al. Human Rabies: A Reemerging Disease in Costa Rica?. Emerg Infect Dis. 2003;9(6):721-723. https://doi.org/10.3201/eid0906.020632 |
---|---|
AMA | Badilla X, Pérez-Herra V, Quirós L, et al. Human Rabies: A Reemerging Disease in Costa Rica?. Emerging Infectious Diseases. 2003;9(6):721-723. doi:10.3201/eid0906.020632. |
APA | Badilla, X., Pérez-Herra, V., Quirós, L., Morice, A., Jiménez, E., Sáenz, E....Rupprecht, C. E. (2003). Human Rabies: A Reemerging Disease in Costa Rica?. Emerging Infectious Diseases, 9(6), 721-723. https://doi.org/10.3201/eid0906.020632. |
Accidental Infection of Laboratory Worker with Vaccinia
We report the accidental needlestick inoculation of a laboratory worker with vaccinia virus. Although the patient had previously been vaccinated against smallpox, severe lesions appeared on the fingers. Western blot and polymerase chain reaction–restriction fragment length polymorphism were used to analyze the virus recovered from the lesions. The vaccinia virus–specific immunoglobulin G levels were measured by enzyme-linked immunosorbent assay. Our study supports the need for vaccination for laboratory workers that routinely handle orthopoxvirus.
EID | Moussatché N, Tuyama M, Kato SE, Castro AP, Njaine B, Peralta RH, et al. Accidental Infection of Laboratory Worker with Vaccinia. Emerg Infect Dis. 2003;9(6):724-726. https://doi.org/10.3201/eid0906.020732 |
---|---|
AMA | Moussatché N, Tuyama M, Kato SE, et al. Accidental Infection of Laboratory Worker with Vaccinia. Emerging Infectious Diseases. 2003;9(6):724-726. doi:10.3201/eid0906.020732. |
APA | Moussatché, N., Tuyama, M., Kato, S. E., Castro, A. P., Njaine, B., Peralta, R. H....Barroso, P. F. (2003). Accidental Infection of Laboratory Worker with Vaccinia. Emerging Infectious Diseases, 9(6), 724-726. https://doi.org/10.3201/eid0906.020732. |
Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan
A prevalence survey in Kabul City showed that 2.7% and 21.9% of persons have active leishmaniasis lesions or scars, respectively. Incidence of disease was estimated to be 2.9% (29 cases/1,000 persons per year; 95% confidence interval 0.018 to 0.031). Disease was associated with age and gender; logistic regression analyses showed significant clustering of cases.
EID | Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, Coleman PG. Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis. 2003;9(6):727-729. https://doi.org/10.3201/eid0906.030026 |
---|---|
AMA | Reithinger R, Mohsen M, Aadil K, et al. Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan. Emerging Infectious Diseases. 2003;9(6):727-729. doi:10.3201/eid0906.030026. |
APA | Reithinger, R., Mohsen, M., Aadil, K., Sidiqi, M., Erasmus, P., & Coleman, P. G. (2003). Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan. Emerging Infectious Diseases, 9(6), 727-729. https://doi.org/10.3201/eid0906.030026. |
Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile–associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confidence interval 2.6 to 61.6) was the strongest risk factor for CDAD.
EID | McCusker ME, Harris AD, Perencevich EN, Roghmann M. Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea. Emerg Infect Dis. 2003;9(6):730-733. https://doi.org/10.3201/eid0906.020385 |
---|---|
AMA | McCusker ME, Harris AD, Perencevich EN, et al. Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea. Emerging Infectious Diseases. 2003;9(6):730-733. doi:10.3201/eid0906.020385. |
APA | McCusker, M. E., Harris, A. D., Perencevich, E. N., & Roghmann, M. (2003). Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea. Emerging Infectious Diseases, 9(6), 730-733. https://doi.org/10.3201/eid0906.020385. |
Absence of Neisseria meningitidis W-135 Electrophoretic Type 37 during the Hajj, 2002
We document the absence of carriage of Neisseria meningitidis W-135 of the sequence type 11 in returning pilgrims after the Hajj 2002. This finding contrasts with the 15% carriage rate we previously reported in pilgrims returning from the Hajj 2001. The epidemiology of carriage may be changing or may have been controlled by vaccination and a policy of administering antibiotics to pilgrims from countries with a high incidence of meningococcal disease.
EID | Wilder-Smith A, Barkham TM, Chew SK, Paton NI. Absence of Neisseria meningitidis W-135 Electrophoretic Type 37 during the Hajj, 2002. Emerg Infect Dis. 2003;9(6):734-737. https://doi.org/10.3201/eid0906.020725 |
---|---|
AMA | Wilder-Smith A, Barkham TM, Chew SK, et al. Absence of Neisseria meningitidis W-135 Electrophoretic Type 37 during the Hajj, 2002. Emerging Infectious Diseases. 2003;9(6):734-737. doi:10.3201/eid0906.020725. |
APA | Wilder-Smith, A., Barkham, T. M., Chew, S. K., & Paton, N. I. (2003). Absence of Neisseria meningitidis W-135 Electrophoretic Type 37 during the Hajj, 2002. Emerging Infectious Diseases, 9(6), 734-737. https://doi.org/10.3201/eid0906.020725. |
Laboratory Surveillance of Dengue in Argentina, 1995–2001
Local transmission of dengue fever virus in Argentina is increased by the presence of Aedes aegypti mosquitoes and dengue outbreaks in neighboring countries. From 1995 to 2001, a laboratory-based active surveillance program detected 922 dengue cases. Indigenous transmission involving dengue-1 and -2 serotypes was confirmed only in subtropical areas in northern Argentina.
EID | Avilés G, Paz MV, Rangeon G, Ranaivoarisoa MY, Verzeri N, Roginski S, et al. Laboratory Surveillance of Dengue in Argentina, 1995–2001. Emerg Infect Dis. 2003;9(6):738-742. https://doi.org/10.3201/eid0906.020483 |
---|---|
AMA | Avilés G, Paz MV, Rangeon G, et al. Laboratory Surveillance of Dengue in Argentina, 1995–2001. Emerging Infectious Diseases. 2003;9(6):738-742. doi:10.3201/eid0906.020483. |
APA | Avilés, G., Paz, M. V., Rangeon, G., Ranaivoarisoa, M. Y., Verzeri, N., Roginski, S....Enria, D. (2003). Laboratory Surveillance of Dengue in Argentina, 1995–2001. Emerging Infectious Diseases, 9(6), 738-742. https://doi.org/10.3201/eid0906.020483. |
Tick-Borne Encephalitis with Hemorrhagic Syndrome, Novosibirsk Region, Russia, 1999
Eight fatal cases of tick-borne encephalitis with unusual hemorrhagic syndrome were identified in 1999 in the Novosibirsk Region, Russia. To study these strains, we sequenced cDNA fragments of protein E gene from six archival formalin-fixed brain samples. Phylogenetic analysis showed tick-borne encephalitis variants clustered with a Far Eastern subtype (homology 94.7%) but not with the Siberian subtype (82%).
EID | Ternovoi VA, Kurzhukov GP, Sokolov YV, Ivanov GY, Ivanisenko VA, Loktev AV, et al. Tick-Borne Encephalitis with Hemorrhagic Syndrome, Novosibirsk Region, Russia, 1999. Emerg Infect Dis. 2003;9(6):743-746. https://doi.org/10.3201/eid0906.030007 |
---|---|
AMA | Ternovoi VA, Kurzhukov GP, Sokolov YV, et al. Tick-Borne Encephalitis with Hemorrhagic Syndrome, Novosibirsk Region, Russia, 1999. Emerging Infectious Diseases. 2003;9(6):743-746. doi:10.3201/eid0906.030007. |
APA | Ternovoi, V. A., Kurzhukov, G. P., Sokolov, Y. V., Ivanov, G. Y., Ivanisenko, V. A., Loktev, A. V....Loktev, V. B. (2003). Tick-Borne Encephalitis with Hemorrhagic Syndrome, Novosibirsk Region, Russia, 1999. Emerging Infectious Diseases, 9(6), 743-746. https://doi.org/10.3201/eid0906.030007. |
Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.
EID | Gordon SB, Kanyanda S, Walsh AL, Goddard K, Chaponda M, Atkinson V, et al. Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi. Emerg Infect Dis. 2003;9(6):747-749. https://doi.org/10.3201/eid0906.030020 |
---|---|
AMA | Gordon SB, Kanyanda S, Walsh AL, et al. Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi. Emerging Infectious Diseases. 2003;9(6):747-749. doi:10.3201/eid0906.030020. |
APA | Gordon, S. B., Kanyanda, S., Walsh, A. L., Goddard, K., Chaponda, M., Atkinson, V....Graham, S. M. (2003). Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi. Emerging Infectious Diseases, 9(6), 747-749. https://doi.org/10.3201/eid0906.030020. |
Letters
Imported West Nile Virus Infection in Europe
EID | Charles P, Zeller H, Bonnotte B, Decasimacker A, Bour J, Chavanet P, et al. Imported West Nile Virus Infection in Europe. Emerg Infect Dis. 2003;9(6):750. https://doi.org/10.3201/eid0906.020723 |
---|---|
AMA | Charles P, Zeller H, Bonnotte B, et al. Imported West Nile Virus Infection in Europe. Emerging Infectious Diseases. 2003;9(6):750. doi:10.3201/eid0906.020723. |
APA | Charles, P., Zeller, H., Bonnotte, B., Decasimacker, A., Bour, J., Chavanet, P....Lorcerie, B. (2003). Imported West Nile Virus Infection in Europe. Emerging Infectious Diseases, 9(6), 750. https://doi.org/10.3201/eid0906.020723. |
Rift Valley Fever Virus Infection among French Troops in Chad
EID | Durand JP, Bouloy M, Richecoeur L, Peyrefitte CN, Tolou HJ. Rift Valley Fever Virus Infection among French Troops in Chad. Emerg Infect Dis. 2003;9(6):751-752. https://doi.org/10.3201/eid0906.020647 |
---|---|
AMA | Durand JP, Bouloy M, Richecoeur L, et al. Rift Valley Fever Virus Infection among French Troops in Chad. Emerging Infectious Diseases. 2003;9(6):751-752. doi:10.3201/eid0906.020647. |
APA | Durand, J. P., Bouloy, M., Richecoeur, L., Peyrefitte, C. N., & Tolou, H. J. (2003). Rift Valley Fever Virus Infection among French Troops in Chad. Emerging Infectious Diseases, 9(6), 751-752. https://doi.org/10.3201/eid0906.020647. |
Corynebacterium ulcerans Diphtheria in Japan
EID | Hatanaka A, Tsunoda A, Okamoto M, Ooe K, Asakura T, Miyakoshi M, et al. Corynebacterium ulcerans Diphtheria in Japan. Emerg Infect Dis. 2003;9(6):752-753. https://doi.org/10.3201/eid0906.020645 |
---|---|
AMA | Hatanaka A, Tsunoda A, Okamoto M, et al. Corynebacterium ulcerans Diphtheria in Japan. Emerging Infectious Diseases. 2003;9(6):752-753. doi:10.3201/eid0906.020645. |
APA | Hatanaka, A., Tsunoda, A., Okamoto, M., Ooe, K., Asakura, T., Miyakoshi, M....Takahashi, M. (2003). Corynebacterium ulcerans Diphtheria in Japan. Emerging Infectious Diseases, 9(6), 752-753. https://doi.org/10.3201/eid0906.020645. |
Salmonella in Birds Migrating through Sweden
EID | Hernandez J, Bonnedahl J, Waldenström J, Palmgren H, Olsen B. Salmonella in Birds Migrating through Sweden. Emerg Infect Dis. 2003;9(6):753-755. https://doi.org/10.3201/eid0906.030072 |
---|---|
AMA | Hernandez J, Bonnedahl J, Waldenström J, et al. Salmonella in Birds Migrating through Sweden. Emerging Infectious Diseases. 2003;9(6):753-755. doi:10.3201/eid0906.030072. |
APA | Hernandez, J., Bonnedahl, J., Waldenström, J., Palmgren, H., & Olsen, B. (2003). Salmonella in Birds Migrating through Sweden. Emerging Infectious Diseases, 9(6), 753-755. https://doi.org/10.3201/eid0906.030072. |
Parachlamydiaceae as Rare Agents of Pneumonia
EID | Greub G, Berger P, Papazian L, Raoult D. Parachlamydiaceae as Rare Agents of Pneumonia. Emerg Infect Dis. 2003;9(6):755-756. https://doi.org/10.3201/eid0906.020613 |
---|---|
AMA | Greub G, Berger P, Papazian L, et al. Parachlamydiaceae as Rare Agents of Pneumonia. Emerging Infectious Diseases. 2003;9(6):755-756. doi:10.3201/eid0906.020613. |
APA | Greub, G., Berger, P., Papazian, L., & Raoult, D. (2003). Parachlamydiaceae as Rare Agents of Pneumonia. Emerging Infectious Diseases, 9(6), 755-756. https://doi.org/10.3201/eid0906.020613. |
Hantaviruses in the Czech Republic
EID | Pejčoch M, Kříž B. Hantaviruses in the Czech Republic. Emerg Infect Dis. 2003;9(6):756-757. https://doi.org/10.3201/eid0906.020772 |
---|---|
AMA | Pejčoch M, Kříž B. Hantaviruses in the Czech Republic. Emerging Infectious Diseases. 2003;9(6):756-757. doi:10.3201/eid0906.020772. |
APA | Pejčoch, M., & Kříž, B. (2003). Hantaviruses in the Czech Republic. Emerging Infectious Diseases, 9(6), 756-757. https://doi.org/10.3201/eid0906.020772. |
Antibiotics and Airline Emergency Medical Kits
EID | Bar-Oz B, Loughran B. Antibiotics and Airline Emergency Medical Kits. Emerg Infect Dis. 2003;9(6):757-758. https://doi.org/10.3201/eid0906.030097 |
---|---|
AMA | Bar-Oz B, Loughran B. Antibiotics and Airline Emergency Medical Kits. Emerging Infectious Diseases. 2003;9(6):757-758. doi:10.3201/eid0906.030097. |
APA | Bar-Oz, B., & Loughran, B. (2003). Antibiotics and Airline Emergency Medical Kits. Emerging Infectious Diseases, 9(6), 757-758. https://doi.org/10.3201/eid0906.030097. |
About the Cover
Pablo Picasso (1881–1973). Guernica (1937).
EID | Potter P. Pablo Picasso (1881–1973). Guernica (1937). . Emerg Infect Dis. 2003;9(6):760-761. https://doi.org/10.3201/eid0906.ac0906 |
---|---|
AMA | Potter P. Pablo Picasso (1881–1973). Guernica (1937). . Emerging Infectious Diseases. 2003;9(6):760-761. doi:10.3201/eid0906.ac0906. |
APA | Potter, P. (2003). Pablo Picasso (1881–1973). Guernica (1937). . Emerging Infectious Diseases, 9(6), 760-761. https://doi.org/10.3201/eid0906.ac0906. |